oVRcome will raise capital to coincide with the publication of our clinical trial results,
currently underway with the University of Otago. This is estimated to be in December 2021.
This will fund our launch into the U.S.
If you're interested in joining our journey, feel free to leave your details below and we'll be in contact
closer to the time. Thanks for your interest.